Tag: COMPASS trial

Digging deep into DOACs for PAD post-revascularization in fight to stave...

This advertorial is sponsored by ACHL “It’s really sad—but it’s true: In the PAD space, we’re really behind. We’re behind in our understanding of the...

Combining aspirin with rivaroxaban reduces risk equally in presence or absence...

In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients...